HLA-A and hepatocellular carcinoma: For epitope prediction, in order to identify potential novel epitopes as the target for innovative HCC-specific immunotherapy strategies, the NetMHCpan software was used to predict binders to the MHC class-I HLA-A*02:01 and 24:02 alleles, which altogether cover about 40% of the world population.